The Main Immunogenic Region of the Acetylcholine Receptor. Structure and Role in Myasthenia Gravis

References

• Changeux J-P, Devillers-Thiery A, Chemouilli P. Acetylcholine receptor, an allosteric protein. Science 1984; 225: 1335–1345
   PubMed Web of Science ®Google Scholar
• McCarthy M P, Earnest J P, Young E F, Choe S, Stroud R M. The molecular neurobiology of the acetylcholine receptor. Ann Rev Neurosci 1986; 9: 383–413
   PubMed Web of Science ®Google Scholar
• Numa S. Structure and function of ionic channels. “Membrane Proteins: Structure, Function, Assembly” in series “Chemica Scripta” vol. 27B, J. Rydstrom, 1987; 5–19
   Google Scholar
• Maelicke A. Structure and function of the nicotinic acetylcholine receptor. Handb of Exp Pharmacol Vol 86, V P Whittaker. Springer Verlag. 1988; 267–313
   Google Scholar
• Hucho F, Oberthur W, Lottspeich F. The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices M II of the receptor subunits. FEBS Lett 1986; 205: 137–142
   PubMed Web of Science ®Google Scholar
• Giraudat J, Dennis M, Heidmann T, Haumont P-Y, Lederer F, Changeux J-P. Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3-H] chlorpromazine labels homologous residues in the β and δ chains. Biochemistry 1987; 26: 2410–2418
   PubMed Web of Science ®Google Scholar
• Myasthenia Gravis. Clin Neurol Neurosurg Monogr vol 5, H JGH. Oosterhuis. Churchill Livingstone, Edinburgh 1984; 1–269
   Google Scholar
• Ann NY Acad Sci 1987; 505: 1–914, Drachman D. Myasthenia Gravis (ed)
   Web of Science ®Google Scholar
• Lindstrom J, Shelton D, Fugii Y. Myasthenia Gravis. Advances in Immunology 1988; 42: 233–284
   PubMed Web of Science ®Google Scholar
• Engel A G. Myasthenia gravis and myasthenic syndromes. Ann Neurol 1984; 16: 519–533
   PubMed Web of Science ®Google Scholar
• Patrick J, Lindstrom J L. Autoimmune response to acetylcholine receptors. Science 1973; 180: 871–872
   PubMed Web of Science ®Google Scholar
• Fambrough D M, Drachman D B, Satiamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 1973; 182: 293–295
   PubMed Web of Science ®Google Scholar
• Harvey A L, Barkas T, Harrison R, Lunt G G. Inhibition of receptor function in cultured chick myotubes by antiserum to purified Torpedo acetylcholine receptor and myasthenic sera. The Biochemistry of Myasthenia Gravis and Muscular Dystrophy, G G Lunt, R M Marchbanks. Academic Press, London 1978; 167–175
   Google Scholar
• Drachman D B, Adams R N, Josifek L F, Self S G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982; 307: 769–775
   PubMed Web of Science ®Google Scholar
• Gomez C M, Richman D P. Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia. Proc Natl Acad Sci USA 1983; 80: 4089–4093
   PubMed Web of Science ®Google Scholar
• Morel E, Vernet der Garabedian B, Eymard B, Raimond F, Bustarret F-A, Bach J-F. Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms. Immunol Res 1988; 7: 212–217
   PubMed Web of Science ®Google Scholar
• Lindstrom J M, Seybold M E, Lennon V A, Whittingham S, Duane D. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Sophianos D, Zimmermann K, Starzinski-Powitz A. Antigenic modulation of human muscle acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization. J Immunol 1986; 136: 3231–3237
   PubMed Web of Science ®Google Scholar
• Hohlfeld R, Toyka K V, Heininger K, Grosse-Wilde H, Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 1984; 310: 244–246
   PubMed Web of Science ®Google Scholar
• Hohlfeld R, Toyka K, Tzartos S J, Carson W, Conti-Tron-Coni B. Human T helper lymphocytes in myasthenia gravis recognize the nicotinic receptor a subunit. Proc Natl Acad Sci USA 1987; 84: 5379–5383
   PubMed Web of Science ®Google Scholar
• Wekerle H, Ketelsen U-P, Zurn A D, Fulpius B W. In-trathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol 1978; 8: 579–582
   PubMed Web of Science ®Google Scholar
• Stefansson K, Dieperink M E, Richman D P, Marton L S. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: A possible role in the pathogenesis of myasthenia gravis. Ann NY Acad Sci 1987; 505: 451–460
   PubMed Web of Science ®Google Scholar
• Kirchner T, Tzartos S, Hoppe F, Schalke B, Wekerle H, Muller-Hermelink H K. Pathogenesis of myastenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. American J Pathol 1988; 130: 268–279
   PubMed Web of Science ®Google Scholar
• Lefvert A K. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis. J Autoimmunity 1988; 1: 63–72
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P L, Dyrbeg T, Drachman D B, Oldstone M BA. Molecular mimicry and Myasthenia Gravis - An au-toantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Inv 1989; 84: 1174–1180
   PubMed Web of Science ®Google Scholar
• Fuchs S, Souroujon M C, Mochly-Rosen D. Antibodies to the acetylcholine receptor. “Monoclonal antibodies to Receptors: Probes for Receptor Structure and Function” in series “Receptors and Recognition” vol B17, M F Greaves. Chapman and Hall. 1984; 163–199
   Google Scholar
• Lindstrom J, Schoepfer R, Whiting P. Molecular studies of the neuronal nicotinic acetylcholine receptor family. Molecular Neurobiology 1987; 1: 281–337
   PubMed Web of Science ®Google Scholar
• Tzartos S J. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor. In Vivo 1987; 2: 105–110
   Google Scholar
• Tzartos S J. Studying the acetylcholine receptor with monoclonal antibodies. “Current Aspects In Neurosciences” Vol 3, N N Osborne. Macmillan Press. 1990; 195–226
   Google Scholar
• Froehner S C. Identification of exposed and buried determinants of the membrane-bound acetylcholine receptor from Torpedo californica. Biochemistry 1981; 20: 4905–4915
   PubMed Web of Science ®Google Scholar
• Sargent P, Hedges B, Tsavaler L, Clemmons L, Tzartos S J, Lindstrom J. The structure and transmembrane nature of the acetylcholine receptor in amphibian skeletal muscle as revealed by cross-reacting monoclonal antibodies. J Cell Biol 1984; 98: 609–618
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Linstrom J L. Monoclonal antibodies to probe acetylcholine receptor structure: Localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 1980; 77: 755–759
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Rand D E, Einarson B E, Lindstrom J M. Mapping of surface structures of Electrophorus acetylcholine receptor using monoclonal antibodies. J Biol Chem 1981; 256: 8635–8645
   PubMed Web of Science ®Google Scholar
• Tzartos S, Langeberg L, Hochschwender S, Lindstrom J. Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett 1983; 158: 116–118
   PubMed Web of Science ®Google Scholar
• Tzartos S, Langeberg L, Hochschwender S, Swanson L, Linstrom J. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity. J Neuroim-munol 1986; 10: 235–253
   PubMed Web of Science ®Google Scholar
• Whiting P J, Vincent A, Newsom-Davis J. Myasthenia gravis: Monoclonal anti-human acetylcholine receptor antbodies used to analyse antibody specificities and responses to treatment. Neurology 1986; 36: 612–617
   PubMed Web of Science ®Google Scholar
• Heidenreich F, Vincent A, Roberts A, Newsom-Davis J. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1988; 1: 285–297
   PubMedGoogle Scholar
• Mihovilovic M, Richman D P. Monoclonal antibodies as probes of the α-bungarotoxin and cholinergic binding regions of the acetylcholine receptor. J Biol Chem 1986; 262: 4978–4986
   Web of Science ®Google Scholar
• Watters D, Maelicke A. Organization of ligand binding sites at the acetylcholine receptor: A study with monoclonal antibodies. Biochemistry 1983; 22: 1811–1819
   PubMed Web of Science ®Google Scholar
• Souroujon M C, Mochly-Rosen D, Gordon A S, Fuchs S. Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle. Muscle Nerve 1983; 6: 303–311
   PubMed Web of Science ®Google Scholar
• James R W, Kato A C, Rey M-J, Fulpius B W. Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor. FEBS Lett 1980; 120: 145–148
   PubMed Web of Science ®Google Scholar
• Lindstrom J M, Engel A G, Seybold M E, Lennon V A, Lambert E H. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J Exp Med 1976; 144: 739–753
   PubMed Web of Science ®Google Scholar
• Ralston S, Sarin V, Thanh H L, River J, Fox J L, Lindstrom J. Synthetic peptides used to locate the a-bungarotoxin binding site and immunogenic regions on a-subunits of the nicotinic acetylcholine receptor. Biochemistry 1987; 26: 3261–3266
   PubMed Web of Science ®Google Scholar
• Mulac-Jericevic B, Kurisaki J-l, Atassi M Z. Profile of the continuous antigenic regins on the extracellular part of the α chain of an acetylcholine receptor. Proc Natl Acad Sci USA 1987; 84: 3633–3637
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Kokla A, Walgrave S, Conti-Tronconi B. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67–76 of the a-subunit. Proc Natl Acad Sci USA 1988; 85: 2899–2903
   PubMed Web of Science ®Google Scholar
• Ratnam M, Sargent P, Sarin V, Fox J L, Le Nguyen D, Rivier J, Criado M, Lindstrom J. Location of antigenic determinants on primary sequences of the subunits of the nicotinic acetylcholine receptor by peptide mapping. Biochemistry 1986; 25: 2621–2632
   PubMed Web of Science ®Google Scholar
• Souroujon M C, Neumann D, Pizzighella S, Safran A, Fuchs S. Localization of a highly immunogenic region on the acetylcholine receptor α subunit. Biochem Biophys Res Commun 1986; 135: 82–89
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Seybold M, Lindstrom J. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 1982; 79: 188–192
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Sophianos D, Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against modulation by human sera. J Immunol 1985; 134: 2343–2349
   PubMed Web of Science ®Google Scholar
• Heidenreich F, Vincent A, Willcox N, Newsom-Davis J. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from Myasthenia gravis patients. Neurology 1988; 38: 1784–1788
   PubMed Web of Science ®Google Scholar
• Shelton G D, Cardient G H, III, Lindstrom J M. Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor. Neurology 1988; 38: 1417–1423
   PubMed Web of Science ®Google Scholar
• Schuetze S M, Vicini S, Hall Z W. Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates. Proc Natl Acad Sci USA 1985; 82: 2533–2537
   PubMed Web of Science ®Google Scholar
• Kordossi A A, Tzartos S J. Mabs against the main immunogenic region of the acetylcholine receptor. Mapping on the intact molecule. J Neuroimmunol 1989; 23: 35–40
   PubMed Web of Science ®Google Scholar
• Ratnam M, Le Nguyen D, Rivier J, Sargent P, Lindstrom J. Transmembrane topography of the nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profile. Biochemistry 1986; 25: 2633–2643
   PubMed Web of Science ®Google Scholar
• Kordossi A, Tzartos S J. Conformation of cytoplasmic segments of acetylcholine receptor α and β subunits probed by monoclonal antibodies. Sensitivity of the antibody competition approach. EM BO J 1987; 6: 1605–1610
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Kordossi A, Walgrave S L, Kokla A, Conti-Tronconi B M. Determination of antibody binding sites on the three-dimensional and primary structure of acetylcholine receptor. Monogr Allergy 1988; 25: 20–32
   PubMedGoogle Scholar
• Tzartos S J, Loutrari H V, Tang F, Kokla A, Walgrave S L, Milius R P, Conti-Tronconi B M. The main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor. Localization and micro-heterogeneity revealed by the use of synthetic peptides. J Neurochem 1990; 54: 51–61
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B, Tzartos S J, Linstrom J. Monoclonal antibodies as probes of acetylcholine receptor structure. II. Binding to native receptor. Biochemistry 1981; 20: 2181–2191
   PubMed Web of Science ®Google Scholar
• Verschuuren J JGM. Experimental autoimmune myasthenia gravis. Antibodies, idiotypes and anti-idiotypes. 1989, Ph D Thesis
   Google Scholar
• Verschuuren J JGM, Graus Y MF, Bos N A, Tzartos S J, Van Breda Vriesman P JC, De Baets M H. Paratope and framework related crossreactive idiotopes on anti-acetylc-holine receptor antibodies. J Immunol 1990, in press
   Web of Science ®Google Scholar
• Killen J, Hochschwender S, Lindstrom J. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies to a predominant idiotype. J Neuroimmunol 1984; 9: 229–241
   Web of Science ®Google Scholar
• Tzartos S J, Starzinski-Powitz A. Decrease in acetylcholine receptor content of human myotube cultures mediated by monoclonal antibodies to α, 4bT and γ subunits. FEBS Lett 1986; 196: 91–95
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Hochschwender S, Vasquez P, Lindstrom J. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J Neuroimmunol 1987; 15: 185–194
   PubMed Web of Science ®Google Scholar
• Kubalek E, Ralston S, Lindstrom J, Unwin N. Location of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo marmorata. J Cell Biol 1987; 105: 9–18
   PubMed Web of Science ®Google Scholar
• Barkas T, Mauron A, Roth B, Alliod C, Tzartos S J, Ballivet M. Mapping the main immunogenic region and toxin binding site of the nicotinic acetylcholine receptor. Science 1987; 235: 77–80
   PubMed Web of Science ®Google Scholar
• Lindstrom J, Tzartos S J, Gullick W. Structure and function of the acetylcholine receptor molecule studied using monoclonal antibodies. Ann NY Acad Sci 1981; 377: 1–19
   PubMed Web of Science ®Google Scholar
• Wan K, Lindstrom J. Effects of monoclonal antibodies on the function of purified acetylcholine receptor from Torpedo Californica reconstituted into liposomes. Biochemistry 1985; 24: 1212–1221
   PubMed Web of Science ®Google Scholar
• Xu Q, DuPont B L, Fairclough R H, Richman D P. An anti-acetylcholine receptor monoclonal antibody that blocks agonist binding also modifies antibody binding to the main immunogenic region of the receptor. Neurology 1988; 38(Suppl. 1)135
   Google Scholar
• Wilson P T, Lentz T L, Hawrot E. Mapping of the alpha-bungarotoxin binding site on the primary amino acid sequence of the Torpedo acetylcholine receptor. Ann NY Acad Sci 1985; 463: 243–246
   Web of Science ®Google Scholar
• Aronheim A, Eshel Y, Mosckovitz R, Gershoni J M. Characterization of the binding of a-bungarotoxin to bacterially expressed cholinergic binding sites. J Biol Chem 1988; 263: 9933–9937
   PubMed Web of Science ®Google Scholar
• Lennon V A., Lambert E H. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann NY Acad Sci 1981; 377: 77–96
   PubMed Web of Science ®Google Scholar
• Lennon V A, Griesmann G E. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology 1989; 39: 1069–1076
   PubMed Web of Science ®Google Scholar
• Chase B A, Holliday J, Reese J H, Chun L LY, Hawrot E. Monoclonal antibodies with defined specificities for Torpedo nicotinic acetylcholine receptor cross-react with Drosophila neural tissue. Neurscience 1987; 21: 959–976
   PubMed Web of Science ®Google Scholar
• Noda M, Takahashi H, Tanabe T, Toyosato M, Furutani Y, Hirose T, Asai M, Inayama S, Miyata T, Numa S. Primary structure of a-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 1982; 299: 793–797
   PubMed Web of Science ®Google Scholar
• Juillerat M A, Barkas T, Tzartos S J. Antigenic sites of the nicotinic acetylcholine receptor cannot be predicted from the hydrophilicity profile. FEBS Lett 1984; 168: 143–148
   PubMed Web of Science ®Google Scholar
• Barkas T, Gabriel J M, Juillerat M, Kokla A, Tzartos S J. Localization of the main immunogenic region of the nicotinic acetylcholine receptor. FEBS Lett 1986; 196: 237–241
   PubMed Web of Science ®Google Scholar
• Barkas T, Gabriel J-M, Mauron A, Hughes G J, Roth B, Alliod C, Tzartos S J, Ballivet M. Fine localisation of the main immunogenic region of the nicotinic acetylcholine receptor to residues 61–76 of the a subunit. J Biol Chem 1988; 263: 5916–5920
   PubMed Web of Science ®Google Scholar
• Wood H, Beeson D, Vincent A, Newsom-Davis J. Epitopes on human acetylcholine receptor a-subunit: binding of monoclonal antibodies to recombinant and synthetic peptides. Biochem Soc Transact 1989; 17: 220–221
   Web of Science ®Google Scholar
• Tzartos S, Papadouli I, Potamianos S, Hadjidakis I, Bairaktari H, Tsikaris V, Sakarellos C, Cung M T, Marraud M. Fine stuctural characterization of the main immunogenic region of the nicotinic acetylcholine receptor. “Molecular Biology of Neuroreceptors and Ion Channels” in NATO ASI series, Vol. H32, A Maelicke, 1989; 361–371
   Google Scholar
• Papadouli I, Potamianos S, Hadjidakis I, Bairaktari E, Tsikaris V, Sakarellos C, Cung M T, Marraud M, Tzartos S J. Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor. Biochem J 1990; 269: 239–245
   PubMed Web of Science ®Google Scholar
• Cung M T, Marraud M, Hadjidakis I, Bairaktari H, Sakarellos C, Kokla A, Tzartos S. 2D-'NMR study of a synthetic peptide containing the main immunogenic region of the Torpedo acetylcholine receptor. Biopolymers 1989; 28: 465–478
   PubMed Web of Science ®Google Scholar
• Cung M T, Marraud M, Bairaktari E, Hadjidakis I, Tsikaris V, Sakarellos C, Papadouli I, Kokla A, Tzartos S J. 2D-NMR study of synthetic main immunogenic region decapeptides related to the myasthenia gravis disease. Bull Magnetic-Resonance 1990, (In Press)
   Google Scholar
• Geysen H M, Meloen H R, Barteling S J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 1984; 81: 3998–4002
   PubMed Web of Science ®Google Scholar
• Das M K, Lindstrom J. The main immunogenic region of the nicotinic acetylcholine receptor. Interaction of monoclonal antibodies with synthetic peptides. Biochem Biophys Res Commun 1989; 165: 865–871
   PubMed Web of Science ®Google Scholar
• Zhang Y, Barkas T, Juilleat M, Schwendimann B, Wekerle H. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the a chain of the nicotinic acetylcholine receptor (Torpedo californica). Eur J Immunol 1988; 18: 551–557
   PubMed Web of Science ®Google Scholar
• Newsom-Davis J, Harcourt G, Sommer N, Beeson D, Willcox N, Rothard J B. T-cell reactivity in Myasthenia Gravis. J Autoimmun 1989; 2: 101–108
   PubMed Web of Science ®Google Scholar
• Swanson L, Lindstrom J, Tzartos S J, Schmued L, O'Leary D D, Cowan W M. Immunohistochemical localization of monoclonal antibodies to the nicotinic acetylcholine receptor in the midbrain of the chick. Proc Natl Acad Sci USA 1983; 80: 4532–4536
   PubMed Web of Science ®Google Scholar
• Halvorsen S W, Berg D K. Affinity labeling of neuronal acetylcholine receptor subunits with an a-neurotoxin that blocks receptor function. J Neurosci 1987; 7: 2547–2555
   PubMed Web of Science ®Google Scholar
• Henley J M, Mynlieff M, Lindstrom J, Oswald R E. Interaction of monoclonal antibodies to electroplaque acetylcholine receptors with the α-bungarotoxin binding site of goldfish brain. Brain Res 1986; 364: 405–408
   PubMed Web of Science ®Google Scholar
• Baldwin T, Yoshihara C M, Blackmer K, Kintner C R, Burden S J. Regulation of acetylcholine receptor transcript expression during development in Xenopus Laevis. J Cell Biol 1988; 106: 469–478
   PubMed Web of Science ®Google Scholar
• Nef P, Oneyser C, Alliod C, Couturier S, Ballivet M. Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. EM BO J 1988; 7: 595–601
   PubMed Web of Science ®Google Scholar
• Wada K, Ballivet M, Boulter J, Connolly J, Wada E, Deneris E S, Swanson L W, Heinemann S, Patrick J. Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor. Science 1988; 240: 330–334
   PubMed Web of Science ®Google Scholar
• Cauley K., Agranoff B W, Goldman D. Identification of a novel nicotinic acetylcholine receptor structural subunit expressed in goldfish retina. J Cell Biol 1989; 108: 637–645
   PubMed Web of Science ®Google Scholar
• Lennon V A, Lambert E H. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 1980; 285: 238–240
   PubMed Web of Science ®Google Scholar
• Heinemann S, Bevan S, Kullberg R, Lindstrom J, Rice J. Modulation of the acetylcholine receptor by anti-receptor antibodies. Proc Natl Acad Sci USA 1977; 74: 3090–3094
   PubMed Web of Science ®Google Scholar
• Sophianos D, Tzartos S J. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against degradation caused by myasthenic sera. J Autoimmun 1989; 2: 777–789
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Morel E, Efthimiadis A, Bustarret A F, Ď Anglejan J, Drosos A, Moutsopoulos H M. Fine antigenic specificities of antibodies in sera from patients with D-Penicillamine-induced myasthenia gravis. Clin Exp Immunol 1988; 74: 80–86
   PubMed Web of Science ®Google Scholar
• McAllister R M, Isaacs H, Rongey R, Peer M, Au W, Soukup S W, Gardner M B. Establishment of a human meduloblas-toma cell line. Int J Cancer 1977; 20: 206–212
   PubMed Web of Science ®Google Scholar
• Stratton M R, Darling J, Pilkington G J, Lantos P L, Reeves B R, Cooper C S. Characterization of the human cell line TE671. Carcinogenesis 1989; 5: 899–905
   Web of Science ®Google Scholar
• Luther M A, Schoepfer R, Whiting P, Casey B, Blatt Y, Montal M S, Montal M, Lindstrom J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblas-toma cell line TE671. J Neurosci 1989; 9: 1082–1096
   PubMed Web of Science ®Google Scholar
• Bellone M, Tang F, Milius R, Conti-Tronconi B M. The main immunogenic region of the nicotinic acetylcholine receptor - identification of amino acid residues interacting with different antibodies. J Immunol 1989; 143: 3568–3579
   PubMed Web of Science ®Google Scholar
• Saedi M S, Anand R, Conroy W G, Linstrom J. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett 1990; 267: 55–59
   PubMed Web of Science ®Google Scholar
• Maelicke A, Plumer-Wilk R, Fels G, Spencer S R, Engelhard M, Veltel D, Conti-Tronconi B M. Epitope mapping employing antibodies raised against short synthetic peptides: A study of the nicotinic acetylcholine receptor. Biochemistry 1989; 28: 1396–1405
   PubMed Web of Science ®Google Scholar
• Criado M, Hochschwender S, Sarin V, Fox J, Lindstrom J. Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits. Proc Natl Acad Sci USA 1985; 82: 2004–2008
   PubMed Web of Science ®Google Scholar
• Pedersen S E, Bridgman P C, Sharp S D, Cohen J B. Identification of a cytoplasmic region of the Torpedo nicotinic acetylcholine receptor alpha-subunit by epitope mapping. J Biol Chem 1990; 265: 569–581
   PubMed Web of Science ®Google Scholar
• Moore C R, Yates J R, Griffin P R, Shabanowitz J, Martino P A, Hunt D F, Cafiso D S. Proteolytic fragments of the nicotinic acetylcholine receptor identified by mass spectrom-ety - implications for receptor topography. Biochemistry 1989; 28: 9184–9191
   PubMed Web of Science ®Google Scholar
• Tzartos S J, Remoundos M S. Fine localization of the major a-bungarotoxin binding site to residues a 189–195 of the Torpedo acetylcholine receptor. Residues 189, 190 and 195 are indispensable for binding. J Biol Chem 1990, In press
   PubMed Web of Science ®Google Scholar
• Dennis M, Giraudat J, Kotsyba-Hilbert F, Goeldner M, Hirth C, Chang J-Y, Lazure C, Chretien M, Changeux J-P. Amino acids of the Torpedo marmorata AChR a subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry 1988; 27: 2346–2357
   PubMed Web of Science ®Google Scholar